This is a regulatory disclosure filed by Ajanta Pharma Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Nomination & Remuneration Committee of the company's Board of Directors, at a meeting held on 30th July 2026, allotted 23,400 fully paid-up equity shares. These shares were issued upon the exercise of employee stock option plan (ESOP) options. Each share has a face value of ₹2.
As a result of this allotment, the company's total paid-up share capital has increased to ₹24,99,18,048. This capital now consists of 12,49,59,024 equity shares, each with a face value of ₹2.
The company stated that it will make an application for the listing of these 23,400 newly allotted equity shares on the stock exchanges in due course.
The disclosure was signed by Gaurang Chinubhai Shah, Sr. VP - Legal & Company Secretary, on 30th July 2024 at 14:49:45 IST.